SE399885B - Forfarande for framstellning av salt av tryptofanderivat med sekretionshemmande och antispastisk verkan - Google Patents
Forfarande for framstellning av salt av tryptofanderivat med sekretionshemmande och antispastisk verkanInfo
- Publication number
- SE399885B SE399885B SE7411375A SE7411375A SE399885B SE 399885 B SE399885 B SE 399885B SE 7411375 A SE7411375 A SE 7411375A SE 7411375 A SE7411375 A SE 7411375A SE 399885 B SE399885 B SE 399885B
- Authority
- SE
- Sweden
- Prior art keywords
- tryptofan
- secretary
- derivatives
- salt
- procedure
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D209/00—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom
- C07D209/02—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom condensed with one carbocyclic ring
- C07D209/04—Indoles; Hydrogenated indoles
- C07D209/10—Indoles; Hydrogenated indoles with substituted hydrocarbon radicals attached to carbon atoms of the hetero ring
- C07D209/18—Radicals substituted by carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals
- C07D209/20—Radicals substituted by carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals substituted additionally by nitrogen atoms, e.g. tryptophane
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Life Sciences & Earth Sciences (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Pharmacology & Pharmacy (AREA)
- Engineering & Computer Science (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Indole Compounds (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US39705173A | 1973-09-13 | 1973-09-13 |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| SE7411375L SE7411375L (fi) | 1975-03-14 |
| SE399885B true SE399885B (sv) | 1978-03-06 |
Family
ID=23569669
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| SE7411375A SE399885B (sv) | 1973-09-13 | 1974-09-09 | Forfarande for framstellning av salt av tryptofanderivat med sekretionshemmande och antispastisk verkan |
Country Status (17)
| Country | Link |
|---|---|
| JP (1) | JPS5231923B2 (fi) |
| AT (1) | AT338258B (fi) |
| AU (1) | AU468784B2 (fi) |
| BE (1) | BE819650A (fi) |
| CA (1) | CA1028332A (fi) |
| CH (1) | CH614195A5 (fi) |
| DE (1) | DE2442303A1 (fi) |
| ES (1) | ES429988A1 (fi) |
| FI (1) | FI58913C (fi) |
| FR (1) | FR2243691B1 (fi) |
| GB (1) | GB1433679A (fi) |
| HK (1) | HK38779A (fi) |
| HU (1) | HU168975B (fi) |
| NL (1) | NL7411211A (fi) |
| NO (1) | NO743260L (fi) |
| SE (1) | SE399885B (fi) |
| ZA (1) | ZA745448B (fi) |
Families Citing this family (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JPS55130556U (fi) * | 1979-03-09 | 1980-09-16 | ||
| JPS6314144Y2 (fi) * | 1979-03-16 | 1988-04-20 |
-
1974
- 1974-08-02 AU AU72870/74A patent/AU468784B2/en not_active Expired
- 1974-08-22 NL NL7411211A patent/NL7411211A/xx unknown
- 1974-08-23 GB GB3722474A patent/GB1433679A/en not_active Expired
- 1974-08-26 ZA ZA00745448A patent/ZA745448B/xx unknown
- 1974-08-28 FI FI2520/74A patent/FI58913C/fi active
- 1974-09-04 DE DE2442303A patent/DE2442303A1/de not_active Withdrawn
- 1974-09-06 BE BE148301A patent/BE819650A/xx not_active IP Right Cessation
- 1974-09-09 SE SE7411375A patent/SE399885B/xx unknown
- 1974-09-11 NO NO743260A patent/NO743260L/no unknown
- 1974-09-11 CH CH1234174A patent/CH614195A5/xx not_active IP Right Cessation
- 1974-09-11 AT AT733774A patent/AT338258B/de not_active IP Right Cessation
- 1974-09-12 FR FR7430928A patent/FR2243691B1/fr not_active Expired
- 1974-09-12 ES ES429988A patent/ES429988A1/es not_active Expired
- 1974-09-12 CA CA209,032A patent/CA1028332A/en not_active Expired
- 1974-09-12 JP JP49105439A patent/JPS5231923B2/ja not_active Expired
- 1974-09-12 HU HURO800A patent/HU168975B/hu unknown
-
1979
- 1979-06-14 HK HK387/79A patent/HK38779A/xx unknown
Also Published As
| Publication number | Publication date |
|---|---|
| NL7411211A (nl) | 1975-03-17 |
| DE2442303A1 (de) | 1975-03-27 |
| JPS5058065A (fi) | 1975-05-20 |
| HK38779A (en) | 1979-06-22 |
| SE7411375L (fi) | 1975-03-14 |
| ZA745448B (en) | 1975-09-24 |
| ES429988A1 (es) | 1976-09-16 |
| FI252074A (fi) | 1975-03-14 |
| ATA733774A (de) | 1976-12-15 |
| FR2243691B1 (fi) | 1978-02-03 |
| JPS5231923B2 (fi) | 1977-08-18 |
| FI58913C (fi) | 1981-05-11 |
| CH614195A5 (en) | 1979-11-15 |
| AT338258B (de) | 1977-08-10 |
| HU168975B (fi) | 1976-08-28 |
| CA1028332A (en) | 1978-03-21 |
| GB1433679A (en) | 1976-04-28 |
| FI58913B (fi) | 1981-01-30 |
| AU468784B2 (en) | 1976-01-22 |
| AU7287074A (en) | 1976-01-22 |
| NO743260L (fi) | 1975-04-07 |
| FR2243691A1 (fi) | 1975-04-11 |
| BE819650A (fr) | 1974-12-31 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| AR207133A1 (es) | Procedimiento para la elaboracion de derivados de 1-piridiloxi 1-pirimidiniloxi y 1-piraziniloxi-2-hidroxi-3-amino-propano | |
| SE395149B (sv) | Forfarande for framstellning av dibenso-tiepinylpiperazinderivat | |
| SE403106B (sv) | Forfarande vid framstellning av 14-hydroximorfinanderivat | |
| SE7611316L (sv) | Prostansyraderivat och sett for framstellning derav | |
| SE401676B (sv) | Forfarande for framstellning av dibensofuranderivat | |
| SE423996B (sv) | Forfarande for framstellning av daunomycin- och adriamycin-derivat | |
| SE421319B (sv) | Forfarande for framstellning av etbara polysackarider och polysackaridderivat | |
| SE407575B (sv) | Forfarande for framstellning av 1,3-dioxanderivat med terapentisk verkan | |
| SE7514308L (sv) | Forfarande for framstellning av tyrosinderivat med terapeutisk verkan | |
| SE392722B (sv) | Forfarande for framstellning av oxazolidinderivat med terapeutisk verkan | |
| SE415659B (sv) | Forfarande for framstellning av basiskt substituerade xanten- och tioxantenderivat | |
| SE398230B (sv) | Forfarande for framstellning av 1-amino-3-/(pyrrody-1)-fenoxi/-2-propanol och derivat derav med terapeutisk verkan | |
| SE409206B (sv) | Forfarande for framstellning av kinoxalindionderivat med hypnotisk verkan | |
| SE399885B (sv) | Forfarande for framstellning av salt av tryptofanderivat med sekretionshemmande och antispastisk verkan | |
| SE400086B (sv) | Forfarande for framstellning av acylerade n(6)- aralkyl-adenosin-derivat | |
| SE385696B (sv) | Nytt forfarande for framstellning av n-(1-etyl-alfa-pyrrolidylmetyl)-2-metoxi-5-sulfamidobensamid med terapeutiska egenskaper | |
| SE396595B (sv) | Forfarande for framstellning av difenylamin och derivat derav | |
| SE404694B (sv) | Forfarande for framstellning av nya 3-alkyl-4-sulfamoylanilinderivat med diuretisk och saluretisk verkan | |
| SE394429B (sv) | Forfarande for framstellning av aminopyrrolderivat med terapeutisk verkan | |
| SE417206B (sv) | Forfarande for framstellning av foreningar med autibiotisk verkan | |
| SE389108B (sv) | Forfarande for framstellning av cyklopropylfenylpyrrolidinderivat med farmakologisk verkan | |
| SE388195B (sv) | Forfarande for framstellning av 2,5-dihydroxibensensulfonsyraderivat med hemostatisk hypokolesterolemisk, hypotriglyceridemisk och hypolipemisk verkan | |
| SE402455B (sv) | Forfarande for framstellning av n-(dietylaminoetyl)-2-metoxi-5-metylsulfonyl-bensamid och dess additionssalter | |
| SE410185B (sv) | Forfarande for framstellning av seko - prostaglandiner med vasodilaterande och blodplettaggregationshemmande effekt | |
| SE420835B (sv) | Forfarande for framstellning av monokromonkarboxylsyror med terapentisk verkan |